
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus
Theresa Currier Thomas, Joshua A. Beitchman, François Pomerleau, et al.
Brain Research (2017) Vol. 1672, pp. 10-17
Open Access | Times Cited: 50
Theresa Currier Thomas, Joshua A. Beitchman, François Pomerleau, et al.
Brain Research (2017) Vol. 1672, pp. 10-17
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 129
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 129
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions
Benjamin Ongnok, Nipon Chattipakorn, Siriporn C. Chattipakorn
Experimental Neurology (2019) Vol. 324, pp. 113118-113118
Closed Access | Times Cited: 102
Benjamin Ongnok, Nipon Chattipakorn, Siriporn C. Chattipakorn
Experimental Neurology (2019) Vol. 324, pp. 113118-113118
Closed Access | Times Cited: 102
Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Microglia in Cancer Therapy-Related Cognitive Impairment
Erin M. Gibson, Michelle Monje
Trends in Neurosciences (2021) Vol. 44, Iss. 6, pp. 441-451
Open Access | Times Cited: 75
Erin M. Gibson, Michelle Monje
Trends in Neurosciences (2021) Vol. 44, Iss. 6, pp. 441-451
Open Access | Times Cited: 75
Cancer related cognitive impairment: a downside of cancer treatment
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation
Ahmad Alhowail, Jenna Bloemer, Mohammed Majrashi, et al.
Toxicology Mechanisms and Methods (2019) Vol. 29, Iss. 6, pp. 457-466
Closed Access | Times Cited: 67
Ahmad Alhowail, Jenna Bloemer, Mohammed Majrashi, et al.
Toxicology Mechanisms and Methods (2019) Vol. 29, Iss. 6, pp. 457-466
Closed Access | Times Cited: 67
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
Erin M. Gibson, Michelle Monje
Current Opinion in Oncology (2019) Vol. 31, Iss. 6, pp. 531-539
Open Access | Times Cited: 45
Erin M. Gibson, Michelle Monje
Current Opinion in Oncology (2019) Vol. 31, Iss. 6, pp. 531-539
Open Access | Times Cited: 45
Experimental Traumatic Brain Injury Induces Chronic Glutamatergic Dysfunction in Amygdala Circuitry Known to Regulate Anxiety-Like Behavior
Joshua A. Beitchman, Daniel R. Griffiths, Yerin Hur, et al.
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 44
Joshua A. Beitchman, Daniel R. Griffiths, Yerin Hur, et al.
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 44
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI)
Laura Catalina Murillo, Jhon Jairo Sutachan, Sonia Luz Albarracín
Toxicology Reports (2023) Vol. 10, pp. 544-553
Open Access | Times Cited: 12
Laura Catalina Murillo, Jhon Jairo Sutachan, Sonia Luz Albarracín
Toxicology Reports (2023) Vol. 10, pp. 544-553
Open Access | Times Cited: 12
Approaches to Monitor Circuit Disruption after Traumatic Brain Injury: Frontiers in Preclinical Research
Gokul Krishna, Joshua A. Beitchman, Caitlin E. Bromberg, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 588-588
Open Access | Times Cited: 31
Gokul Krishna, Joshua A. Beitchman, Caitlin E. Bromberg, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 588-588
Open Access | Times Cited: 31
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity
Blake McAlpin, Rajasekaran Mahalingam, Anand Kumar Singh, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 603-619
Open Access | Times Cited: 26
Blake McAlpin, Rajasekaran Mahalingam, Anand Kumar Singh, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 603-619
Open Access | Times Cited: 26
Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 593-608
Closed Access | Times Cited: 9
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 593-608
Closed Access | Times Cited: 9
Chemotherapy-induced cognitive impairment and glia: A new take on chemobrain?
Maria Barbosa-Azevedo, Ana Dias-Carvalho, Félix Carvalho, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117085-117085
Open Access | Times Cited: 3
Maria Barbosa-Azevedo, Ana Dias-Carvalho, Félix Carvalho, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117085-117085
Open Access | Times Cited: 3
5-Fluorouracil impairs attention and dopamine release in rats
David P. Jarmolowicz, Rachel C. Gehringer, Shea M. Lemley, et al.
Behavioural Brain Research (2019) Vol. 362, pp. 319-322
Open Access | Times Cited: 28
David P. Jarmolowicz, Rachel C. Gehringer, Shea M. Lemley, et al.
Behavioural Brain Research (2019) Vol. 362, pp. 319-322
Open Access | Times Cited: 28
Traumatic Brain Injury-Induced Sex-Dependent Changes in Late-Onset Sensory Hypersensitivity and Glutamate Neurotransmission
Gokul Krishna, Caitlin E. Bromberg, Emily Connell, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 26
Gokul Krishna, Caitlin E. Bromberg, Emily Connell, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 26
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Modeling neurotoxin-induced neuroinflammation with chemotherapy
Mai F. Tolba, Nada K. Sedky, Marwa A. Ali, et al.
Elsevier eBooks (2022), pp. 403-417
Closed Access | Times Cited: 14
Mai F. Tolba, Nada K. Sedky, Marwa A. Ali, et al.
Elsevier eBooks (2022), pp. 403-417
Closed Access | Times Cited: 14
NMDA Receptor-Mediated Excitotoxicity Is Involved in Neuronal Apoptosis and Cognitive Impairment Induced by Chronic Hypobaric Hypoxia Exposure at High Altitude
Weizhong Ji, Yaqing Zhang, Ri‐Li Ge, et al.
High Altitude Medicine & Biology (2020) Vol. 22, Iss. 1, pp. 45-57
Closed Access | Times Cited: 21
Weizhong Ji, Yaqing Zhang, Ri‐Li Ge, et al.
High Altitude Medicine & Biology (2020) Vol. 22, Iss. 1, pp. 45-57
Closed Access | Times Cited: 21
Protective effect of nanocurcumin against neurotoxicity induced by doxorubicin in rat’s brain
Yasser A. Khadrawy, Eman N. Hosny, Haitham S. Mohammed
NeuroToxicology (2021) Vol. 85, pp. 1-9
Closed Access | Times Cited: 18
Yasser A. Khadrawy, Eman N. Hosny, Haitham S. Mohammed
NeuroToxicology (2021) Vol. 85, pp. 1-9
Closed Access | Times Cited: 18
Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery
Yuqiong He, Cancan Zhou, Shenggui Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Yuqiong He, Cancan Zhou, Shenggui Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2